[11C]MDL 100907, a radioligand for selective imaging of 5-HT2A receptors with positron emission tomography
- 2 February 1996
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 58 (10), 187-192
- https://doi.org/10.1016/0024-3205(96)00013-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- An open clinical and biochemical study of ritanserin in acute patients with schizophreniaPsychopharmacology, 1994
- Loss of brain 5-HT2receptors in Alzheimer's diseaseBrain, 1993
- 5-HT2 and D2 dopamine receptor occupancy in the living human brainPsychopharmacology, 1993
- Ligands and tracers for PET studies of the 5-HT system—current statusInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992
- New Antipsychotics: Classification, Efficacy, and Adverse EffectsSchizophrenia Bulletin, 1991
- The Mechanism of Action of Novel Antipsychotic DrugsSchizophrenia Bulletin, 1991
- 3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortexJournal of Neuroscience, 1986
- Drug‐receptor dissociation time, new tool for drug research: Receptor binding affinity and drug‐receptor dissociation profiles of serotonin‐S2, Dopamine‐D2, histamine‐H1 antagonists, and opiatesDrug Development Research, 1986
- Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PETScience, 1986